Can the IFU be signed electronically?

Yes; electronic signatures are valid under the ESIGN Act (15 U.S.C. ch. 96) and UETA when intent, consent, attribution, and durable recordability are present. Certain exceptions (for example, wills or specific court filings) may still require wet signatures or additional procedures.

What authentication should signers use?

Select authentication proportional to risk: email link or SMS codes for lower-risk attestations; SSO, identity-proofing, or KBA for higher-risk approvals. FDA-regulated records may require 21 CFR Part 11-compliant controls and stronger signer authentication.

Is a BAA required when IFUs contain PHI?

Yes. If the IFU contains protected health information, HIPAA requires a Business Associate Agreement with the eSignature vendor and appropriate technical safeguards; retain related records in accordance with 45 CFR §164.530(j).

Are notarization or witnesses required for IFUs?

Generally not for routine IFUs, but state law and institutional policy can vary. Remote online notarization (RON) is authorized in many states with identity proofing, audio-video recording, and retention obligations; verify state notary rules before requiring notarization.

How long should signed IFUs be retained?

Retention depends on content and regulation: HIPAA requires six years for PHI (45 CFR §164.530(j)), financial records follow IRS minima (IRC §6501(a)), and many organizations retain clinical device records seven years or longer per institutional policy.

What if the signer name doesn't match ID?

A name mismatch weakens attribution and can raise enforceability questions. Use exact legal names, require ID verification for high-risk transactions, and correct errors by re-execution or amendment with proper authentication to preserve auditability under ESIGN/UETA standards.

Healthcare IFU Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Healthcare IFU Form

Purpose: This Instructions for Use (IFU) Form documents the provision of written and verbal instructions related to a medical device, equipment, or prescribed treatment, and the patient's acknowledgement of receipt, understanding, and intention to comply with the instructions. Patient information, clinical history relevant to safe use, device/procedure details, warnings, and the patient certification are included below.

Patient Information

Full Legal Name Date of Birth Gender Address

Primary Phone:

Email:

Emergency Contact (Name, Relationship, Phone)

Insurance Information

Insurer / Plan Name

Policy Number:

Group Number:

Subscriber Name:

Relevant Medical History

Current Medications Allergies (medication, latex, adhesives) Prior Surgeries / Procedures Chronic Conditions

Device / Procedure / Treatment Details

Device / Medication / Procedure Name

Model / Serial / Lot #:

Date Provided:

Intended Use / Indication Step-by-Step Instructions for Use

Important: Follow the provided steps exactly. Deviations may increase risk of injury, infection, device malfunction, or lack of therapeutic effect. If any step is unclear, do not proceed and contact the clinician prior to use.

Warnings, Contraindications, and Risks

Warnings: The device/medication/procedure may present risks including but not limited to infection, allergic reaction, bleeding, tissue damage, device failure, or other adverse events. Contraindications include known allergy to materials used, unstable clinical condition, or other conditions identified by the clinician. The list of potential adverse events is not exhaustive.

Specific Risks Discussed with Patient

Benefits: The anticipated benefits and expected outcome were explained by the clinician, including the intended clinical effect and alternatives when applicable.

Storage, Maintenance, and Disposal

Patient Responsibilities and Follow-Up

The patient is responsible for adhering to instructions, attending scheduled follow-up appointments, performing any required self-assessments, and reporting unexpected symptoms promptly. Failure to follow instructions may result in harm or reduced therapeutic effect.

Follow-Up Appointment Date

HIPAA & Privacy Acknowledgment

I acknowledge that I have received the facility's privacy practices and that information related to my treatment, device issuance, or procedure will be handled in accordance with applicable privacy laws. I consent to use of my health information for treatment, billing, and care coordination as described.

I acknowledge receipt of the privacy practices and consent to the permitted uses of my health information.

Authorization and Expiration

This IFU acknowledgement grants permission for the clinician and care team to provide the device, instructions, and necessary follow-up care. This authorization expires on the date specified below unless earlier revoked in writing.

Authorization Expiration Date

Patient Certification

By signing below, I certify that I have received the written Instructions for Use and that a clinician has reviewed the instructions with me. I understand the intended use, the steps necessary for safe operation, the risks and benefits, and the storage and disposal requirements. I have had the opportunity to ask questions and my questions have been answered to my satisfaction. I understand I may withdraw my consent at any time by notifying the clinician in writing, and that withdrawing consent may affect the provision of future services.

Additional Notes (clinician or patient)

Patient Name:

Signature:

Relationship to Patient (if signing for patient):

Date:

What the Healthcare IFU Form Is and when it's used

The Healthcare IFU Form documents Instructions for Use (IFU) associated with medical devices, supplies, or clinical procedures used in patient care. It consolidates device identification, intended use, step-by-step operational instructions, safety warnings, contraindications, maintenance schedules, and disposal guidance into a single standardized record. Healthcare providers, biomedical engineers, and regulatory teams use the form to ensure consistent training and compliance with manufacturer guidance and institutional policies. The form also creates an auditable record useful for quality management, incident investigation, and evidence during regulatory inspections.

Why a formal Healthcare IFU Form matters

The Healthcare IFU Form documents safe device use and establishes consent, responsibility, and audit trails. Electronic execution is generally enforceable under ESIGN (15 U.S.C. ch. 96) and UETA; healthcare workflows must also meet HIPAA privacy requirements.

Primary users and responsibilities

Primary users include clinicians, biomedical engineering staff, regulatory officers, and device manufacturers responsible for IFU accuracy, updates, and distribution.

Hospital clinicians: nurses and physicians who follow IFU steps during procedures and document deviations.
Biomedical engineers: implement maintenance, perform verification, and record service per IFU schedules.
Regulatory and quality teams: manage version control, training, and audit records for inspections.

Use role-based distribution to ensure each stakeholder receives the correct IFU version and training documentation.

Core sections every Healthcare IFU Form should include

Core sections define device identity, intended use, stepwise instructions, warnings, maintenance, and version control to support safe clinical operation and regulatory compliance.

Device ID

Record model, serial number, lot/batch, manufacturer name, and catalog numbers; include UDI where applicable and cross-reference device service records for traceability during investigations and regulatory submissions.

Intended Use

Describe clinical indications, target patient population, contraindications, and typical use settings; reference FDA-cleared indications or manufacturer labeling where applicable, including clinically relevant limitations and off-label warnings.

Step-by-Step

Provide sequential actions with timing, required tools, visual aids, and checkpoints; specify acceptable parameter ranges and criteria for successful completion and troubleshooting tips for common deviations.

Warnings

List safety warnings, potential adverse events, contraindicated conditions, and emergency steps; include symbols and prominence standards to meet regulatory labeling requirements and references to clinical support documentation.

Maintenance

Document cleaning, sterilization, calibration schedules, parts replacement intervals, and required tools; state responsible role and recordkeeping expectations for each maintenance activity including cross-references to service logs and validation certificates.

Version Control

Include revision number, effective date, author, approver, and change summary; maintain distribution list and archive superseded IFUs for audit and compliance, with retention timelines and justification for material changes.

Step-by-step: complete, verify, and publish an IFU

Follow these sequential steps to populate, review, and approve the Healthcare IFU Form before distribution and clinical use.

01

Prepare Document: Gather device specs, manufacturer IFU, and maintenance history.
02

Fill Fields: Complete identifiers, intended use, stepwise instructions, and warnings.
03

Review & Verify: Clinical and engineering teams validate content and tolerances.
04

Approve & Distribute: Authorized signers date and publish controlled version to staff.

Configure an online workflow for Healthcare IFU Form completion

Configure an online IFU workflow to automate version control, signer routing, and storage in the clinical document management system.

Field	Configuration
Signing Order	Sequential approval by role-based signers.
Authentication Level	Email link, SMS code, or SSO per policy.
Conditional Fields	Show maintenance tasks only for serviceable models.
Storage Location	Archive in clinical DMS with immutable audit log.

Digital signing and integration requirements for IFU workflows

Ensure platform supports PDF, DOCX, import, audit trails, and HIPAA BAA options for PHI handling.

File Formats: PDF, DOCX, and optional HTML supported
Integrations: EHR, Microsoft 365, Google Workspace, NetSuite
Signer Verification: Email, SMS, SSO, KBA, and audit trail

Where completed IFUs are sent and stored

Routes determine where completed IFUs are stored, who receives copies, and how change notifications reach clinical teams.

Internal Repository: Store signed IFU in institutional DMS for clinical access.
EHR Attachment: Attach summarized IFU to patient record when procedure-specific.
Manufacturer: Send authenticated copy to device manufacturer per policy.
Regulatory Filing: Retain version for inspections and incident reporting.

Typical timelines and processing expectations for IFU updates

Timelines govern IFU approval, distribution, review cycles, and mandatory updates after adverse events or manufacturer revisions.

Initial Draft Multidisciplinary Content Review:

Complete multidisciplinary review within 10 business days.

Clinical Lead Final Approval and Sign-off:

Sign-off by clinical lead within 5 business days.

Engineering Calibration and Maintenance Verification Process:

Calibration and maintenance validation within 14 days.

Controlled Document Distribution to Clinical Staff:

Publish controlled version to staff within 2 business days.

Post-Event Update and Regulatory Notification:

Revise IFU within 30 days after adverse event notification.

Common mistakes to avoid when preparing an IFU

Incomplete device identifiers lead to misapplied procedures, recall tracking failures, and delays during audits or incident investigations.
Vague or missing contraindications increase patient risk and expose the facility to liability and regulatory noncompliance.
Failing to record maintenance and sterilization steps can void warranties, violate manufacturer requirements, and hinder root-cause analysis.
Distributing uncontrolled versions without version control or audit trails undermines accountability and complicates compliance during inspections.

Key legal and operational risks from incorrect IFUs

Patient Harm: Increased adverse events risk

Regulatory Action: Fines or inspection notices

Liability Exposure: Civil suits and indemnity claims

Warranty Void: Manufacturer may deny repairs

Audit Findings: Nonconformities recorded

Operational Delays: Service interruptions and backlog

Security and compliance controls to include with IFU handling

Encryption: TLS 1.2/1.3 in transit; AES-256 at rest

Access Controls: Role-based permissions and granular field restrictions

Audit Trails: Complete timestamps, IP, and action log

HIPAA BAA: Business Associate Agreement required for PHI

Authentication: Email, SMS, SSO, and optional KBA

Certifications: SOC 2 Type II, ISO 27001, PCI DSS

eSignature vendor comparison for Healthcare IFU Form handling

Key plan and compliance criteria for eSignature vendors when handling Healthcare IFU Forms and protected health information (PHI).

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	Yes, 7-day trial	Varies	Varies	Varies	Varies
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Frequently asked questions about Healthcare IFU Forms and e-signatures

Answers to common technical, legal, and operational questions about completing, signing, and storing Healthcare IFU Forms.

Need help? Contact support

Can the IFU be signed electronically?
Yes; electronic signatures are valid under the ESIGN Act (15 U.S.C. ch. 96) and UETA when intent, consent, attribution, and durable recordability are present. Certain exceptions (for example, wills or specific court filings) may still require wet signatures or additional procedures.
What authentication should signers use?
Select authentication proportional to risk: email link or SMS codes for lower-risk attestations; SSO, identity-proofing, or KBA for higher-risk approvals. FDA-regulated records may require 21 CFR Part 11-compliant controls and stronger signer authentication.
Is a BAA required when IFUs contain PHI?
Yes. If the IFU contains protected health information, HIPAA requires a Business Associate Agreement with the eSignature vendor and appropriate technical safeguards; retain related records in accordance with 45 CFR §164.530(j).
Are notarization or witnesses required for IFUs?
Generally not for routine IFUs, but state law and institutional policy can vary. Remote online notarization (RON) is authorized in many states with identity proofing, audio-video recording, and retention obligations; verify state notary rules before requiring notarization.
How long should signed IFUs be retained?
Retention depends on content and regulation: HIPAA requires six years for PHI (45 CFR §164.530(j)), financial records follow IRS minima (IRC §6501(a)), and many organizations retain clinical device records seven years or longer per institutional policy.
What if the signer name doesn't match ID?
A name mismatch weakens attribution and can raise enforceability questions. Use exact legal names, require ID verification for high-risk transactions, and correct errors by re-execution or amendment with proper authentication to preserve auditability under ESIGN/UETA standards.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now